Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Coffee Rd
Modesto, CA 95355Phone+1 209-550-4795
Education & Training
UPMC Medical EducationResidency, Internal Medicine, 2015 - 2018
University of Pittsburgh School of MedicineClass of 2015
Johns Hopkins UniversityM.S. and B.S., Molecular and Cell Biology, 2006 - 2010
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2017 - 2025
OR State Medical License 2018 - 2023
PA State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 12 citationsMultiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies.Marilyne Labrie, Allen G. Li, Allison L. Creason, Courtney Betts, Jamie M. Keck
NPJ Precision Oncology. 2021-10-19 - 1 citationsExceptional Response to Pembrolizumab and Trastuzumab in a Heavily Pretreated Patient With HER2-Positive TMB-H and MSI-H Metastatic Breast CancerAllen G. Li, Shaun M. Goodyear, Cristina Fuss, Zahi Mitri
JCO Precision Oncology. 2021-06-01 - 16 citationsCharacterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics.Allen G. Li, Jamie M. Keck, Swapnil Parmar, Janice Patterson, Marilyne Labrie
NPJ Precision Oncology. 2021-03-26
Journal Articles
- Genomic Alteration in Metastatic Breast Cancer and its Treatment.Li A, Schleicher SM, Andre F, Mitri ZI., American Society of Clinical Oncology Educational Book. 2020(40):30-43.
Abstracts/Posters
- Feasibility of real-time serial comprehensive tumor analytics: Pilot study of olaparib and durvalumab in metastatic triple negative breast cancer (mTNBC).Li A, Labrie M, Vuky J, Lim JY, Johnson B, Sivagnanam S, Betts C, Coussens L, Corless C, Bergan R, Gray J, Mills G, Mitri Z., ASCO 2020
- Comparison of Circulating Tumor DNA (ctDNA) sequencing and Tumor-based Genotyping for the Detection of EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC).Li A, Dacic S, Burns T, Socinsk, M, Abberbock S, Villaruz L, ASCO 2017
- Autophagy activity and SMAD4 Status in Patients with Primary Resectable Pancreatic Adenocarcinoma.Li A, Zenati M, Krasinskas A, Steve J, Lotze M, Zeh H., Academic Surgical Congress 2013
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
